11th Jan 2016 09:10
LONDON (Alliance News) - Pharmaceutical industry services company Ergomed PLC on Monday said it has moved its chief financial officer over to run its trading subsidiary and has appointed a new finance chief in his place.
Ergomed said Neil Clark, currently its chief financial officer, will become the chief executive of PrimeViligance, Ergomed's drug safety and medical information trading arm.
Due to his move, Stephen Stamp has joined the company from US-based personalised medicine group AssureRx Health Inc as chief financial officer. He held the same role at his previous employer and was in the past the finance director of office space provider Regus PLC and of Shire PLC.
Ergomed shares were untraded Monday morning, having last traded at 172.00 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
ERGO.L